1. The protocol is still in its infancy, and is developing an improving over time - But research, development and cinical trials takes time.
2. Essentially, gene therapy is inserting functional genes into an unspecified genomic location in order to replace a mutated gene - but this is, almost by definition, short lived, since you encounter problems trying to integrate the therapeutic DNA into a genome consisting of rapidly dividing cells. Gene therapy, at least as it is mostly practiced, is not the lifetime replacement of a defective or mutant gene.
3. Sometimes the carrier of the therapeutic DNA can provoke a severe immune response, curtailing the treatment.
By SCID,are you referring to Severe Combined Immunodeficiency? If memory serves, they did attempt such a treatment - but the replacement DNA was incorrectly integrated in the genome, in this case the tumour suppressor gene, and in at least some of the patients, a tumour developed. As a consequence, the research and gene therapy treatment were immediately shut down - but it is an area that probably should be looked at again.
http://scienceblogs.c...and_x-linked_scid.php